Active	Status	Sponsor type	Region	Phase	Filter
35 Active 10 Inactive 45 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

10 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Clemmensen, Peter
OCTOBER, NCT03171311: The Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction	Active, not recruiting	N/A	1201	Europe	Angiographic guided PCI, PCI, percutaneous transluminal coronary angioplasty (PTCA), OCT guided PCI, OCT	Aarhus University Hospital Skejby, Abbott	Ischaemic Heart Disease, Ischemic Heart Disease	03/22	05/29
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial	Recruiting	N/A	1247	Europe, Canada, US	Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System	Edwards Lifesciences	Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation	01/25	04/30
Nielsen-Kudsk, Jens Erik
NCT05567172: Watchman FLX Pro CT Pilot Study	Active, not recruiting	N/A	45	Europe	Left atrial appendage closure device WM FLX Pro	Boston Scientific Corporation	Non-valvular Atrial Fibrillation (AF)	11/24	11/25
NCT05324371: A Pilot Study to Assess WATCHMAN FLX™ Implants by Cardiac Computed Tomography, Magnetic Resonance Imaging and Transesophageal Echocardiography: WATCHMAN FLX™ CT	Completed	N/A	25	Europe	Watchman FLX Device	Boston Scientific Corporation	The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial Fibrillation	05/24	01/25
NCT06580275: The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure	Recruiting	N/A	80	Europe, RoW	CLAAS	Conformal Medical, Inc	Atrial Fibrillation, Stroke Prevention	06/25	12/25
ABT-CIP-10523, NCT06707688: Abbott Medical - VERITAS Study	Recruiting	N/A	475	Europe, Canada, US	Amulet™ 2 Left Atrial Appendage (LAA) Occluder	Abbott Medical Devices	Atrial Fibrillation (AF), Stoke	07/26	07/28
CATALYST, NCT04226547: Amplatzer Amulet LAAO Vs. NOAC	Recruiting	N/A	2650	Europe, Canada, Japan, US, RoW	Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder), Amplatzer Amulet LAA Occluder, Non-Vitamin K Oral Antagonists, NOAC	Abbott Medical Devices	Atrial Fibrillation, Stroke, Bleeding	08/27	08/30
NCT05069558: Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion	Active, not recruiting	N/A	450	Europe, Canada, US	Investigational PFO Closure Device, Standard of Care PFO Closure Device	Occlutech International AB	Stroke, Patent Foramen Ovale, PFO	11/25	10/26
Hjermind, Lena
NCT05032196: Study of WVE-003 in Patients With Huntington's Disease	Completed	1/2	47	Europe, Canada, RoW	WVE-003	Wave Life Sciences Ltd.	Huntington Disease	05/24	05/24
NCT05822908 / 2022-001314-19: A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD	Recruiting	1/2	65	Europe, RoW	VO659	Vico Therapeutics B. V., VICO Therapeutics B.V.	Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, Huntington Disease	09/25	09/25
Huitz, Elizabeth
No trials found
Hansen, Christina V
No trials found
Thudium, Rebekka F
No trials found
Hove-Skovsgaard, Malene
No trials found